Myriad Genetics | MYGN - Ebitda


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Myriad Genetics

Myriad Genetics reported $-32800000 in EBITDA for its fiscal quarter ending in March of 2023.


Ebitda Change
Accelerate Diagnostics AXDX:US USD -15260000 2.09M
Agilent A:US USD 472M 33M
Becton, Dickinson and Co. BDX:US USD 1.29B 54M
Bruker BRKR:US USD 151.3M 9.9M
Danaher DHR:US USD 2.32B 538M
Exact Sciences EXAS:US USD -27279000 38.66M
Hologic HOLX:US USD 342.3M 7.1M
Illumina ILMN:US USD 15M 73M
J&J JNJ:US USD 9B 934.8M
Myriad Genetics MYGN:US USD -32800000 500K
NanoString Technologies NSTG:US USD -37014000 2.7M
OraSure Technologies OSUR:US USD 31.73M 14.53M
Pacific Biosciences Of California PACB:US USD -91024000 10.42M
Quest Diagnostics DGX:US USD 431M 129M
Quidel QDEL:US USD 180.1M 49.4M
Repligen RGEN:US USD 48.78M 577K
Thermo Fisher Scientific TMO:US USD 2.56B 204M
Waters WAT:US USD 205.58M 112.02M